Recent Insider Transactions • Jun 08
Insider recently sold US$200k worth of stock On the 1st of June, Daniel Norman sold around 10k shares on-market at roughly US$20.64 per share. This transaction amounted to 32% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$475k. Insiders have been net sellers, collectively disposing of US$2.2m more than they bought in the last 12 months. Recent Insider Transactions • May 26
Executive VP recently sold US$262k worth of stock On the 21st of May, Nathan Brower sold around 12k shares on-market at roughly US$21.84 per share. This transaction amounted to 22% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$475k. Insiders have been net sellers, collectively disposing of US$2.0m more than they bought in the last 12 months. Reported Earnings • May 11
First quarter 2026 earnings: EPS exceeds analyst expectations First quarter 2026 results: EPS: US$0.29 (up from US$0.26 in 1Q 2025). Revenue: US$122.9m (up 8.5% from 1Q 2025). Net income: US$5.12m (up 7.8% from 1Q 2025). Profit margin: 4.2% (in line with 1Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 41%. Revenue is forecast to grow 4.7% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 31% per year. Annonce • May 03
Nature’S Sunshine Products, Inc. Appoints John Hnanicek as Chief Technology Officer, Effective May 4, 2026 Nature’s Sunshine Products, Inc. announced that John Hnanicek has been appointed Chief Technology Officer, effective May 4, 2026. Mr. Hnanicek brings decades of senior leadership experience in technology, digital innovation, and e-commerce transformation across leading consumer, retail, and direct-to-consumer organizations. He most recently served as Chief Digital Innovation Officer at Melaleuca, where he led enterprise-wide digital initiatives, technology modernization, and customer innovation efforts. Prior to Melaleuca, Mr. Hnanicek held senior technology and innovation leadership roles at The Vitamin Shoppe, where he served as Chief Customer Innovation and Technology Officer and Chief Information Officer, leading enterprise technology, digital commerce, and customer engagement initiatives. Earlier in his career, he served as SVP and Chief Information Officer at Charming Charlie and held executive technology leadership roles at organizations including Altrec.com, Knowledge Learning Corporation, Paciolan, Inc., eToys, Hollywood Entertainment, and OfficeMax. Throughout his career, Mr. Hnanicek has demonstrated a strong track record of leading large-scale digital transformations, modernizing enterprise systems, and enabling growth through technology, data, and innovation. He holds a Bachelor of Science in Computer Science from Cleveland State University. Annonce • Apr 24
Nature's Sunshine Products, Inc. to Report Q1, 2026 Results on May 07, 2026 Nature's Sunshine Products, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 07, 2026 Annonce • Mar 30
Nature's Sunshine Products, Inc., Annual General Meeting, May 06, 2026 Nature's Sunshine Products, Inc., Annual General Meeting, May 06, 2026. Location: 2901 west bluegrass blvd, suite 100, utah 84048, lehi United States Recent Insider Transactions • Mar 17
Insider recently sold US$99k worth of stock On the 13th of March, Jonathan Lanoy sold around 4k shares on-market at roughly US$24.70 per share. This transaction amounted to 7.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$910k more than they bought in the last 12 months. Reported Earnings • Mar 11
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: US$1.08 (up from US$0.41 in FY 2024). Revenue: US$480.1m (up 5.7% from FY 2024). Net income: US$19.5m (up 154% from FY 2024). Profit margin: 4.1% (up from 1.7% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.3%. Revenue is forecast to grow 4.6% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 41% per year whereas the company’s share price has increased by 37% per year. Annonce • Mar 11
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2026 Nature's Sunshine Products, Inc. provided earnings guidance for the full year 2026. For the year, the company expects net sales to range between $500 million- $515 million. Price Target Changed • Mar 10
Price target increased by 21% to US$26.00 Up from US$21.50, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of US$25.08. Stock is up 73% over the past year. The company is forecast to post earnings per share of US$1.09 for next year compared to US$0.41 last year. Annonce • Feb 25
Nature's Sunshine Products, Inc. to Report Q4, 2025 Results on Mar 10, 2026 Nature's Sunshine Products, Inc. announced that they will report Q4, 2025 results on Mar 10, 2026 Buy Or Sell Opportunity • Feb 03
Now 21% undervalued Over the last 90 days, the stock has risen 83% to US$25.85. The fair value is estimated to be US$32.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.2% over the last 3 years. Earnings per share has grown by 32%. Revenue is forecast to grow by 5.2% in 2 years. Earnings are forecast to grow by 41% in the next 2 years. Annonce • Dec 04
Nature's Sunshine Products, Inc. Appoints Erich Fritz as Executive Vice President of Global Supply Chain, Effective December 8, 2025 Nature’s Sunshine Products, Inc. announced that Erich Fritz has been named Executive Vice President, Global Supply Chain, effective December 8, 2025. Mr. Fritz will report directly to Ken Romanzi, the Company’s Chief Executive Officer. Mr. Fritz brings over 40 years of executive experience in operations, supply chain, and business development, with a proven track record of driving growth, operational efficiency, and innovation at leading consumer goods companies. His leadership spans Fortune 500 organizations and entrepreneurial ventures, including Wyandot Snacks, B&G Foods, Ocean Spray Cranberries, POM Wonderful, Naked Juice, and Nabisco. Mr. Fritz joins Nature’s Sunshine from Wyandot Snacks, where he served as Chief Operating Officer and a member of the Board of Directors, leading operational strategies to improve infrastructure, efficiency, and financial performance. Previously, as EVP and Chief Supply Chain Officer at B&G Foods, he oversaw supply chain operations for 50+ brands across nine manufacturing facilities, integrating major acquisitions and delivering significant cost reductions. At Ocean Spray Cranberries, he led manufacturing across twelve manufacturing facilities, engineering, and research and development, spearheading the design and construction of North America’s largest Ocean Spray beverage plant and driving innovation in product development and supply chain management. Throughout his career, Mr. Fritz has demonstrated success in building business frameworks, leading acquisitions and divestitures, and implementing advanced automation and ERP systems. He holds a BS in Management from St. Mary’s College of California and has been named as inventor on several patents related to food and beverage processing. Recent Insider Transactions • Nov 20
Insider recently sold US$102k worth of stock On the 18th of November, Jonathan Lanoy sold around 5k shares on-market at roughly US$20.45 per share. This transaction amounted to 9.8% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$162k. Insiders have been net sellers, collectively disposing of US$591k more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Nov 14
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to US$21.15, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Personal Products industry in the US. Total returns to shareholders of 137% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$31.63 per share. Reported Earnings • Nov 07
Third quarter 2025 earnings: EPS and revenues exceed analyst expectations Third quarter 2025 results: EPS: US$0.30 (up from US$0.23 in 3Q 2024). Revenue: US$128.3m (up 12% from 3Q 2024). Net income: US$5.33m (up 23% from 3Q 2024). Profit margin: 4.2% (up from 3.8% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.7%. Earnings per share (EPS) also surpassed analyst estimates by 87%. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 32% per year whereas the company’s share price has increased by 30% per year. Price Target Changed • Nov 07
Price target increased by 9.8% to US$22.50 Up from US$20.50, the current price target is an average from 2 analysts. New target price is 26% above last closing price of US$17.92. Stock is up 20% over the past year. The company posted earnings per share of US$0.41 last year. Annonce • Nov 07
Nature's Sunshine Products, Inc. Raises Earnings Guidance for the Year 2025 Nature's Sunshine Products, Inc. raised earnings guidance for the year 2025. For the year, the company expects net sales to range between $476 million - $480 million ($460 million - $475 million prior). Annonce • Oct 24
Nature's Sunshine Products, Inc. to Report Q3, 2025 Results on Nov 06, 2025 Nature's Sunshine Products, Inc. announced that they will report Q3, 2025 results on Nov 06, 2025 Annonce • Oct 08
Nature's Sunshine Products, Inc. Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis Nature's Sunshine Products, Inc. announced the relaunch of its Power Line suite of products with the addition of the newly launched Power Balance supplement. The enhanced product line features four supplements designed to address the growing metabolic health challenges facing millions of people worldwide. The Power Line leverages traditional superfood wisdom combined with modern nutritional science to deliver comprehensive metabolic support. Developed to be a complete superfood system, the relaunched Power Line includes refinements to three favorites alongside an exciting new addition: Power Balance. Power Beets - A cardiovascular performance booster harnessing the natural power of beetroot to improve oxygen delivery, increase stamina and boost heart function. Power Greens - A supercharged nutrient complex built around premium, nutrient-dense greens and vegetables to fill nutritional gaps, boost metabolism and alleviate stress. Power Meal - An ancient superfood and plant protein meal replacement featuring traditional root vegetables, immune-boosting mushrooms and over 30 whole foods. New Power Balance - A premeal metabolic optimizer that features a superfood fiber matrix, it's the natural, drug-free way to curb cravings, balance blood sugar and strengthen the microbiome. The Power Line relaunch comes at a critical time as metabolic health concerns continue to rise globally. These convenient, nutrient-rich supplements are designed to bridge the nutritional gaps in modern diets and optimize metabolic health. The new Power Balance represents the company's natural, superfood approach to combatting the metabolic health crisis. Offering a superfood fiber matrix featuring natural fruit fibers and phytonutrients, it works synergistically with the other Power Line products to support metabolic wellness goals. Recent Insider Transactions • Aug 17
Insider recently sold US$83k worth of stock On the 13th of August, Jonathan Lanoy sold around 5k shares on-market at roughly US$16.51 per share. This transaction amounted to 9.1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Major Estimate Revision • Aug 07
Consensus EPS estimates increase by 18% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from US$461.0m to US$467.2m. EPS estimate increased from US$0.785 to US$0.93 per share. Net income forecast to grow 20% next year vs 25% growth forecast for Personal Products industry in the US. Consensus price target up from US$20.50 to US$21.50. Share price rose 9.6% to US$15.35 over the past week. Reported Earnings • Aug 01
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Second quarter 2025 results: EPS: US$0.29 (up from US$0.072 in 2Q 2024). Revenue: US$114.8m (up 3.8% from 2Q 2024). Net income: US$5.33m (up 295% from 2Q 2024). Profit margin: 4.6% (up from 1.2% in 2Q 2024). Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 75%. Revenue is forecast to grow 2.7% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 14% per year. Annonce • Aug 01
Nature's Sunshine Products, Inc. Updates Earnings Guidance for the Full Year 2025 Nature's Sunshine Products, Inc. updated earnings guidance for the full year 2025. For the year, the company now expects net sales to range between $460 million - $475 million ($445 million - $470 million prior). Annonce • Jul 18
Nature's Sunshine Products, Inc. to Report Q2, 2025 Results on Jul 31, 2025 Nature's Sunshine Products, Inc. announced that they will report Q2, 2025 results on Jul 31, 2025 Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to US$14.33, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 18x in the Personal Products industry in the US. Total returns to shareholders of 16% over the past three years. Reported Earnings • May 08
First quarter 2025 earnings: EPS and revenues exceed analyst expectations First quarter 2025 results: EPS: US$0.26 (up from US$0.12 in 1Q 2024). Revenue: US$113.2m (up 2.0% from 1Q 2024). Net income: US$4.75m (up 105% from 1Q 2024). Profit margin: 4.2% (up from 2.1% in 1Q 2024). Revenue exceeded analyst estimates by 3.6%. Earnings per share (EPS) also surpassed analyst estimates by 52%. Revenue is forecast to grow 1.7% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 5% per year. Price Target Changed • May 07
Price target decreased by 9.1% to US$20.00 Down from US$22.00, the current price target is an average from 2 analysts. New target price is 51% above last closing price of US$13.25. Stock is down 16% over the past year. The company is forecast to post earnings per share of US$0.78 for next year compared to US$0.41 last year. Annonce • May 07
Nature's Sunshine Products, Inc. Reaffirms Earnings Guidance for the Full Year of 2025 Nature's Sunshine Products, Inc. reaffirmed earnings guidance for the full year of 2025. For the year, the company continues to expect full year 2025 net sales to range between $445 million to $470 million. Annonce • May 06
Nature’s Sunshine Products, Inc. Announces Change in Chairman of the Board of Directors Nature’s Sunshine Products, Inc. announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature’s Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields (“R+F”), the leading skincare brand in North America, Ms. Wissmiller led the company to more than $1 billion in incremental revenue growth, expanding its powerful community of female entrepreneurs to over 300,000 and customer base to 1.8 million. She also led the creation and launch of R+F Virtual, for which she received two co-patents, and was featured as a keynote speaker at IBM Think convention and Salesforce Dreamforce Conference. Ms. Wissmiller currently serves as Chairman of the Board of Trustees of the New York Film Academy 10 ARTS Foundation. Annonce • Apr 23
Nature's Sunshine Products, Inc. to Report Q1, 2025 Results on May 06, 2025 Nature's Sunshine Products, Inc. announced that they will report Q1, 2025 results on May 06, 2025 Reported Earnings • Mar 12
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: EPS: US$0.41 (down from US$0.79 in FY 2023). Revenue: US$454.4m (up 2.0% from FY 2023). Net income: US$7.70m (down 49% from FY 2023). Profit margin: 1.7% (down from 3.4% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 38%. Revenue is forecast to grow 2.2% p.a. on average during the next 2 years, compared to a 3.5% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Annonce • Mar 12
Nature's Sunshine Products, Inc. Provides Financial Guidance for Full Year 2025 Nature's Sunshine Products, Inc. provides financial guidance for full year 2025. For the period, the company expects net sales to range between $445 million to $470 million. Annonce • Mar 04
Nature's Sunshine Products, Inc. Launches First Integrated Brand Platform Nature's Sunshine Products, Inc. announced the launch of its new brand platform, "Be More Earth." In the brand's first integrated platform created in partnership with media and creative agency Crispin, the spotlight is on Nature's Sunshine's storied history of harnessing nature's healing powers and sharing it with consumers. The entire brand platform and visual design are inspired by the Earth - its uniqueness, natural beauty and restorative power - while honoring over 50 years of sourcing the finest ingredients it has to offer. The new brand tone is rooted in honesty, humility, and awe of what the Earth can do. Nature's Sunshine lets the ingredients speak for themselves. This comes through in the visual language as well, showcasing purity of elements and ingredients, honesty in real and raw details, and progress in the way that humans are represented in a state of symbiosis with the earth. Illustration was used to express relationship with Earth beyond the mineral, working with artist Thomas Danthony. New work launches March 3rd on Nature's Sunshine website, email, storefronts and all branded touchpoints, and across paid media including Meta, Pinterest, Reddit, Vox, YouTube, CTV and Influencer. Crispin was responsible for strategy, brand platform and positioning, visual design strategy, web, and media. Annonce • Feb 26
Nature's Sunshine Products, Inc. to Report Q4, 2024 Results on Mar 11, 2025 Nature's Sunshine Products, Inc. announced that they will report Q4, 2024 results on Mar 11, 2025 Annonce • Feb 06
Nature's Sunshine Products, Inc. Appoints Katie A. May to Board of Directors Nature's Sunshine Products, Inc. announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. Ms. May was previously the founder and Chief Executive Officer of Kidspot, an Australia based online publisher, eventually selling to News Corp. in 2011. Katie became Chief Executive Officer at ShippingEasy, a Sydney based start-up in 2012, moved it to Austin, Texas, and built this ecommerce software solution to a leading player in the space, exiting to Stamps.com in mid-2016, joining their board in 2019. Following Stamps.com's acquisition of ShippingEasy, Katie also assumed leadership of St. Louis-based Shipworks, overseeing both companies until her retirement in 2020. Ms. May serves on the boards of directors of Vivi International Pty Ltd., Australian education technology company, since February 2020, ROKT Pte Ltd., a global leader in ecommerce marketing technology, since July 2020, and Onramp Funds, Inc., a financing technology platform, since March 2021. Ms. May previously served on the board of directors of Stamps.com, Inc., Thinkific Labs, Inc. and Pitney Bowes Inc. Ms. May received an M.B.A. from The University of Texas at Austin and B.B.A. in Accounting from The University of Texas at Austin. Annonce • Nov 12
Nature’s Sunshine Appoints Steven Fasching to Board of Directors Nature's Sunshine Products, Inc. announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors. Since June 2018, Fasching has served as the Chief Financial Officer of Deckers Brands, which includes iconic brands such as UGG®, Hoka® and Teva®. Fasching has held other senior positions at Deckers Brands since August 2011, including Vice President, Strategy & Investor Relations and Vice President, Strategic Financial Planning. Fasching has over 30 years of experience in long-term financial and strategic planning for multi-billion-dollar organizations. Fasching received a B.S. degree in Business Administration from Pepperdine University and an M.B.A. from The Anderson School of Management at UCLA. He also completed The Executive Program for Prospective Chief Financial Officers through the University of Chicago Booth School of Business. Annonce • Nov 08
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2024 Nature's Sunshine Products, Inc. provided earnings guidance for the full year 2024. For the period, the company expects net sales to range between $443 - $448 million ($436 - $445 million prior). Annonce • Oct 25
Nature's Sunshine Products, Inc. to Report Q3, 2024 Results on Nov 07, 2024 Nature's Sunshine Products, Inc. announced that they will report Q3, 2024 results on Nov 07, 2024 Annonce • Sep 17
Nature's Sunshine Products, Inc. Appoints Kevin Fuller as Global Chief Marketing Officer, Effective September 23, 2024 Nature’s Sunshine Products, Inc. announced the appointment of Kevin Fuller as Global Chief Marketing Officer, effective September 23, 2024. Fuller, a seasoned marketing executive with over two decades of experience in high-performance organizations, brings in-depth global marketing experience to Nature’s Sunshine. His deep understanding of the dietary supplement industry combined with his experience launching new products, building powerful brands, and driving customer growth strategies make Fuller an ideal fit for Nature’s Sunshine. Fuller joins Nature’s Sunshine from Helo Health, where he served as President and Chief Marketing Officer. Prior to his time with Helo Health, he was CEO and Chief Marketing Officer at MacuVu Macular Health where he developed the company’s go-to-market strategy, brand identity, and product launch plans. Prior to that, he led NuSkin’s marketing organization, as Senior Vice President, Global Product & Brand where he built a global marketing engine that improved consumer insights, modernized campaigns, and built an innovative product pipeline to drive sustainable growth. Earlier in his career, Fuller held key marketing roles at Pharmanex and USANA. Fuller holds an MBA from Brigham Young University, a B.S. in Biology from the University of Utah, and was a member of the Kellogg school’s Executive Education Program for Digital Marketing. He is also an accomplished triathlete, competing in four Ironman World Championships, was selected as a member of the USA World Championship Triathlon Team in 2023 and is a current 3-time All American. He is also a member of the Advisory Board of Unleash Health. Annonce • Aug 28
Nature's Sunshine Products, Inc. Addresses Spanish Fork Manufacturing Facility Incident Nature’s Sunshine Products, Inc. announced that an equipment malfunction occurred at their Spanish Fork, Utah manufacturing facility early in the morning of August 26, 2024. The facility was evacuated and local emergency services were called to the scene to help manage the incident. All personnel are safe and accounted for, and two individuals were seen by EMTs and released to leave the facility. The company is working to determine the cause of the malfunction, which resulted in a small fire, and to assess the extent of the damage to the facility. A portion of the facility will temporarily be closed for repairs while normal operations continue in unaffected areas. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to US$12.38, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 15x in the Personal Products industry in the US. Total loss to shareholders of 25% over the past three years. Major Estimate Revision • Aug 15
Consensus EPS estimates fall by 29% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$455.8m to US$438.9m. EPS estimate also fell from US$0.72 per share to US$0.51 per share. Net income forecast to shrink 23% next year vs 55% growth forecast for Personal Products industry in the US . Consensus price target of US$21.00 unchanged from last update. Share price fell 16% to US$12.38 over the past week. Price Target Changed • Aug 12
Price target decreased by 13% to US$21.00 Down from US$24.00, the current price target is provided by 1 analyst. New target price is 78% above last closing price of US$11.79. Stock is down 30% over the past year. The company is forecast to post earnings per share of US$0.51 for next year compared to US$0.79 last year. Annonce • Aug 11
Nature's Sunshine Products, Inc. Revises Earnings Guidance for the Full Year 2024 Nature's Sunshine Products, Inc. revised earnings guidance for the full year 2024. For the period, the company now expects full year 2024 net sales to range between $436 - $445 million ($455 - $480 million prior). Reported Earnings • Aug 09
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Second quarter 2024 results: EPS: US$0.072 (down from US$0.13 in 2Q 2023). Revenue: US$110.6m (down 5.1% from 2Q 2023). Net income: US$1.35m (down 44% from 2Q 2023). Profit margin: 1.2% (down from 2.1% in 2Q 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 61%. Revenue is forecast to grow 6.0% p.a. on average during the next 2 years, compared to a 6.5% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Annonce • Jul 26
Nature's Sunshine Products, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Nature's Sunshine Products, Inc. announced that they will report Q2, 2024 results on Aug 08, 2024 Valuation Update With 7 Day Price Move • May 14
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to US$15.51, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 18x in the Personal Products industry in the US. Total loss to shareholders of 19% over the past three years. Major Estimate Revision • May 14
Consensus EPS estimates fall by 14% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$467.9m to US$455.8m. EPS estimate also fell from US$0.84 per share to US$0.72 per share. Net income forecast to shrink 13% next year vs 23% growth forecast for Personal Products industry in the US . Consensus price target down from US$24.00 to US$23.00. Share price fell 19% to US$15.51 over the past week. Annonce • May 09
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2024 Nature's Sunshine Products, Inc. provided earnings guidance for the full year 2024. The Company continues to expect full year 2024 net sales to range between $455 - $480 million. Reported Earnings • May 08
First quarter 2024 earnings: EPS misses analyst expectations First quarter 2024 results: EPS: US$0.12 (up from US$0.045 in 1Q 2023). Revenue: US$111.0m (up 2.2% from 1Q 2023). Net income: US$2.32m (up 170% from 1Q 2023). Profit margin: 2.1% (up from 0.8% in 1Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 29%. Revenue is forecast to grow 4.5% p.a. on average during the next 2 years, compared to a 6.7% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Annonce • Apr 24
Nature's Sunshine Products, Inc. to Report Q1, 2024 Results on May 07, 2024 Nature's Sunshine Products, Inc. announced that they will report Q1, 2024 results on May 07, 2024 Major Estimate Revision • Mar 19
Consensus EPS estimates increase by 15% The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate increased from US$0.73 to US$0.84. Revenue forecast steady at US$467.9m. Net income forecast to grow 8.1% next year vs 29% growth forecast for Personal Products industry in the US. Consensus price target up from US$21.50 to US$24.00. Share price rose 14% to US$19.71 over the past week. Annonce • Mar 17
Nature's Sunshine Products, Inc., Annual General Meeting, May 01, 2024 Nature's Sunshine Products, Inc., Annual General Meeting, May 01, 2024, at 10:00 Mountain Daylight. New Risk • Mar 13
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 0% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Reported Earnings • Mar 13
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: US$0.79 (up from US$0.02 loss in FY 2022). Revenue: US$445.3m (up 5.5% from FY 2022). Net income: US$15.1m (up US$15.5m from FY 2022). Profit margin: 3.4% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 64%. Revenue is forecast to grow 5.4% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Annonce • Mar 13
Nature's Sunshine Products, Inc. Provides Earnings Guidance for the Full Year 2024 Nature's Sunshine Products, Inc. provided earnings guidance for the full year 2024. For the period, the company expects net sales to range between $455 million to $480 million. Buy Or Sell Opportunity • Mar 11
Now 20% undervalued Over the last 90 days, the stock has risen 6.1% to US$17.24. The fair value is estimated to be US$21.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.1% over the last 3 years. Earnings per share has declined by 44%. Revenue is forecast to grow by 9.7% in 2 years. Earnings are forecast to grow by 91% in the next 2 years. Annonce • Feb 21
Nature's Sunshine Products, Inc. to Report Q4, 2023 Results on Mar 12, 2024 Nature's Sunshine Products, Inc. announced that they will report Q4, 2023 results on Mar 12, 2024 Buying Opportunity • Dec 12
Now 20% undervalued Over the last 90 days, the stock is up 1.6%. The fair value is estimated to be US$20.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.1% over the last 3 years. Earnings per share has declined by 44%. Revenue is forecast to grow by 9.7% in 2 years. Earnings is forecast to grow by 91% in the next 2 years. Recent Insider Transactions • Dec 04
Insider recently sold US$257k worth of stock On the 30th of November, Daniel Norman sold around 15k shares on-market at roughly US$17.13 per share. This transaction amounted to 37% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$628k more than they bought in the last 12 months. Recent Insider Transactions • Nov 28
Executive VP recently sold US$69k worth of stock On the 21st of November, Nathan Brower sold around 4k shares on-market at roughly US$17.31 per share. This transaction amounted to 17% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$371k more than they bought in the last 12 months. New Risk • Nov 10
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 24% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Reported Earnings • Nov 09
Third quarter 2023 earnings: EPS exceeds analyst expectations Third quarter 2023 results: EPS: US$0.15 (up from US$0.005 in 3Q 2022). Revenue: US$111.2m (up 6.4% from 3Q 2022). Net income: US$2.83m (up US$2.74m from 3Q 2022). Profit margin: 2.5% (up from 0.1% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 15%. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 6.2% growth forecast for the Personal Products industry in the US. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. 
